Trial | NCT01354184  Report issue

Title

CRD007 for the Treatment of Abdominal Aorta Aneurysm (The AORTA Trial)
An International, Multi-centre, Randomised, Stratified, Double-blinded, Placebo-controlled, 4-parallel Group Trial Investigating the Efficacy and Safety of Three Different Dose Levels of CRD007 (The AORTA Trial)

  • Phase

    Phase 2

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    pemirolast ...

  • Study Participants

    None
This is an investigation of the efficacy and safety of CRD007 compared to placebo in the treatment of patients with abdominal aortic aneurysm.
Study Started
May 13
2011
Last Update
Nov 06
2012
Estimate

Drug CRD007

Drug CRD007 matching placebo

CRD007 10 mg tablet Experimental

CRD007 25 mg tablet Experimental

CRD007 40 mg tablet Experimental

CRD007 matching placebo tablet Placebo Comparator

Criteria 

Inclusion Criteria:

Infra-renal abdominal aortic aneurysm

Exclusion Criteria:

Previous infra-renal aortic surgery
Known diabetes
No Results Posted